Labeling error spurs Canada’s Aphria to recall medical cannabis

A licensed producer of medical marijuana in Ontario has recalled a small amount of dried marijuana due to a labeling error.

Leamington, Ontario-based Aphria issued the voluntary recall for two lots of dried marijuana sold in 10-gram bottles produced between Jan. 19 and Jan. 22.

The labels failed to include a percent sign next to the numerical values for cannabinoid content, according to recall notification from Health Canada.

The recall was initiated Jan. 25.

It’s a Type III recall, meaning affected products are unlikely to cause adverse health consequences.

Health Canada said it hasn’t received any reports of adverse reactions.

An Aphria spokesperson didn’t immediately return a call from Marijuana Business Daily.

It’s the second time in less than a year Aphria has recalled medical cannabis because of a labeling mishap.

On March 8, 2017, the company voluntary recalled dried marijuana because of mislabeling.

Meanwhile, three of Canada’s 10 MMJ recalls in the past year have stemmed from labeling errors. Aurora Cannabis’ recall in November is the most recent incident.

Aphria and Aurora are traded on the Toronto Stock Exchange under the symbols APH and ACB, respectively.

To sign up for our weekly Canada marijuana business newsletter, click here.